releases: https://www.mccaskill.senate.gov/media-center/video/view/mccaskill-facts-underlying-this-hearing-are-so-egregious-its-hard-not-to-get-emotional-about-it
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.mccaskill.senate.gov/media-center/video/view/mccaskill-facts-underlying-this-hearing-are-so-egregious-its-hard-not-to-get-emotional-about-it | McCaskill: ‘Facts Underlying This Hearing Are So Egregious, It’s Hard Not to Get Emotional About It’ | 2015-12-11 | 2015 | 2015-12 | Democrat | House | MO | Claire McCaskill | M001170 | www.mccaskill.senate.gov | legacy | U.S. Senator Claire McCaskill today helped lead the first in a series of hearings on dramatic drug price increasesoften on older, off-patent drugsafter the acquisition or merger of pharmaceutical companies. The hearing, entitled Sudden Price Spikes in Off-Patent Drugs: Perspectives from the Front Lines explored the causes of these sudden, aggressive price hikes on off-patent drugs and the effect these egregious price increases have on patients access to medication. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |